ATE277912T1 - Pyrimidine-2,4,6-trione als matrixmetalloproteinase-hemmer - Google Patents
Pyrimidine-2,4,6-trione als matrixmetalloproteinase-hemmerInfo
- Publication number
- ATE277912T1 ATE277912T1 AT00907524T AT00907524T ATE277912T1 AT E277912 T1 ATE277912 T1 AT E277912T1 AT 00907524 T AT00907524 T AT 00907524T AT 00907524 T AT00907524 T AT 00907524T AT E277912 T1 ATE277912 T1 AT E277912T1
- Authority
- AT
- Austria
- Prior art keywords
- matrixmetalloproteinase
- trione
- pyrimidine
- inhibitor
- matrixmetalloproteinase inhibitor
- Prior art date
Links
- HNYOPLTXPVRDBG-UHFFFAOYSA-N barbituric acid Chemical compound O=C1CC(=O)NC(=O)N1 HNYOPLTXPVRDBG-UHFFFAOYSA-N 0.000 title 1
- 229940121386 matrix metalloproteinase inhibitor Drugs 0.000 title 1
- 239000003771 matrix metalloproteinase inhibitor Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/60—Three or more oxygen or sulfur atoms
- C07D239/62—Barbituric acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Rheumatology (AREA)
- Ophthalmology & Optometry (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11990399P | 1999-02-12 | 1999-02-12 | |
PCT/EP2000/001016 WO2000047565A1 (en) | 1999-02-12 | 2000-02-09 | Pyrimidine-2,4,6-triones as inhibitors of matrix metalloproteinases |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE277912T1 true ATE277912T1 (de) | 2004-10-15 |
Family
ID=22387100
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT00907524T ATE277912T1 (de) | 1999-02-12 | 2000-02-09 | Pyrimidine-2,4,6-trione als matrixmetalloproteinase-hemmer |
Country Status (16)
Country | Link |
---|---|
US (1) | US6265578B1 (de) |
EP (1) | EP1153015B1 (de) |
JP (1) | JP3655551B2 (de) |
KR (1) | KR100477160B1 (de) |
CN (1) | CN1147481C (de) |
AR (1) | AR035008A1 (de) |
AT (1) | ATE277912T1 (de) |
AU (1) | AU774487B2 (de) |
BR (1) | BR0008109A (de) |
CA (1) | CA2361605C (de) |
DE (1) | DE60014323T2 (de) |
ES (1) | ES2226790T3 (de) |
PT (1) | PT1153015E (de) |
TR (1) | TR200102334T2 (de) |
WO (1) | WO2000047565A1 (de) |
ZA (1) | ZA200106214B (de) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AP2001002319A0 (en) * | 2000-10-26 | 2001-12-31 | Pfizer Prod Inc | Pyrimidine-2,4,6-trione metalloproteinase inhibitors. |
US6841671B2 (en) | 2000-10-26 | 2005-01-11 | Pfizer Inc. | Spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors |
CN1501937A (zh) * | 2000-10-26 | 2004-06-02 | �Ʒ� | 螺-嘧啶-2,4,6-三酮金属蛋白酶抑制剂 |
AU2002346729A1 (en) | 2001-12-20 | 2003-07-09 | Bristol-Myers Squibb Company | Barbituric acid derivatives as inhibitors of tnf-$g(a) converting enzyme (tace) and/or matrix metalloproteinases |
WO2003090751A1 (en) | 2002-04-26 | 2003-11-06 | Pfizer Products Inc. | Pyrimidine-2, 4, 6-trione metallo-proteinase inhibitors |
CA2483075A1 (en) | 2002-04-26 | 2003-11-06 | Pfizer Products Inc. | Triaryl-oxy-aryl-spiro-pyrimidine-2, 4, 6-trione metalloproteinase inhibitors |
MXPA04010545A (es) | 2002-04-26 | 2005-01-25 | Pfizer Prod Inc | Inhibidores de metaloproteinasa de heteroariloxi-aril-espiero-pirimidina-2,4,6-triona n-sustituida. |
NI200300045A (es) * | 2002-04-26 | 2005-07-08 | Pfizer Prod Inc | Inhibidores de triariloxiariloxipirimidin-2,4,6-triona de metaloproteinasa. |
TWI280128B (en) * | 2002-05-22 | 2007-05-01 | Smithkline Beecham Corp | 3'-[(2Z)-[1-(3,4- dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene]hydrazino]-2'-hydroxy-[1,1'-biphenyl]-3-carboxylic acid bis-(monoethanolamine) |
AU2003253165A1 (en) * | 2002-08-13 | 2004-02-25 | Warner-Lambert Company Llc | Pyrimidine fused bicyclic metalloproteinase inhibitors |
ES2305753T3 (es) * | 2003-08-22 | 2008-11-01 | Singulus Technologies Ag | Metodo para el pegado de sustratos en forma de disco y aparato para llevar a cabo el metodo. |
RU2400233C1 (ru) | 2009-07-07 | 2010-09-27 | Общество с ограниченной ответственностью "Вирфарм" | Способ лечения заболеваний печени различного генеза |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19548624A1 (de) | 1995-12-23 | 1997-06-26 | Boehringer Mannheim Gmbh | Neue Barbitursäure-Derivate, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel |
CA2294259A1 (en) | 1997-06-21 | 1998-12-30 | Roche Diagnostics Gmbh | Barbituric acid derivatives with antimetastatic and antitumor activity |
DE19726427A1 (de) | 1997-06-23 | 1998-12-24 | Boehringer Mannheim Gmbh | Pyrimidin-2,4,6-trion-Derivate, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel |
-
2000
- 2000-01-17 US US09/483,858 patent/US6265578B1/en not_active Expired - Fee Related
- 2000-02-09 AT AT00907524T patent/ATE277912T1/de not_active IP Right Cessation
- 2000-02-09 CN CNB008035261A patent/CN1147481C/zh not_active Expired - Fee Related
- 2000-02-09 EP EP00907524A patent/EP1153015B1/de not_active Expired - Lifetime
- 2000-02-09 TR TR2001/02334T patent/TR200102334T2/xx unknown
- 2000-02-09 WO PCT/EP2000/001016 patent/WO2000047565A1/en active IP Right Grant
- 2000-02-09 BR BR0008109-4A patent/BR0008109A/pt not_active Application Discontinuation
- 2000-02-09 PT PT00907524T patent/PT1153015E/pt unknown
- 2000-02-09 CA CA002361605A patent/CA2361605C/en not_active Expired - Fee Related
- 2000-02-09 ES ES00907524T patent/ES2226790T3/es not_active Expired - Lifetime
- 2000-02-09 AU AU29085/00A patent/AU774487B2/en not_active Ceased
- 2000-02-09 JP JP2000598486A patent/JP3655551B2/ja not_active Expired - Fee Related
- 2000-02-09 DE DE60014323T patent/DE60014323T2/de not_active Expired - Lifetime
- 2000-02-09 KR KR10-2001-7010209A patent/KR100477160B1/ko not_active IP Right Cessation
- 2000-02-10 AR ARP000100594A patent/AR035008A1/es unknown
-
2001
- 2001-07-27 ZA ZA200106214A patent/ZA200106214B/en unknown
Also Published As
Publication number | Publication date |
---|---|
TR200102334T2 (tr) | 2002-01-21 |
KR100477160B1 (ko) | 2005-03-17 |
EP1153015A1 (de) | 2001-11-14 |
EP1153015B1 (de) | 2004-09-29 |
ZA200106214B (en) | 2002-10-28 |
CA2361605A1 (en) | 2000-08-17 |
DE60014323T2 (de) | 2006-02-16 |
AR035008A1 (es) | 2004-04-14 |
AU774487B2 (en) | 2004-07-01 |
CN1339028A (zh) | 2002-03-06 |
JP2002536439A (ja) | 2002-10-29 |
PT1153015E (pt) | 2004-12-31 |
CA2361605C (en) | 2009-01-27 |
AU2908500A (en) | 2000-08-29 |
ES2226790T3 (es) | 2005-04-01 |
WO2000047565A1 (en) | 2000-08-17 |
KR20020011963A (ko) | 2002-02-09 |
US6265578B1 (en) | 2001-07-24 |
BR0008109A (pt) | 2001-11-06 |
CN1147481C (zh) | 2004-04-28 |
DE60014323D1 (de) | 2004-11-04 |
JP3655551B2 (ja) | 2005-06-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EE200300195A (et) | Pürimidiin-2,4,6-trioonmetalloproteinaasi inhibiitorid | |
CY2015035I1 (el) | Ενωσεις πυριμιδινης | |
IL148035A0 (en) | Pyrimidine-2,4,6-trione metalloproteinase inhibitors | |
NO20024127L (no) | Pyrimidin-forbindelser | |
DK1175408T3 (da) | Pyrimidinonforbindelser | |
IL154948A0 (en) | Spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors | |
DK1002795T3 (da) | HIV-replikationsinhiberende pyrimidiner | |
ATE372988T1 (de) | Pyrimidin-derivate | |
DE60019577D1 (de) | 4, 5, 6, 7-tetrahydroindazolderivate als antitumormittel | |
DE60036430D1 (de) | Werkzeughalter | |
NL1014361A1 (nl) | Bevestigingsorgaan. | |
EE200200275A (et) | Immunosupressantidena kasutatavad 2,4-diaminopürimidiiniühendid | |
ID28483A (id) | 2-(3,5-bis-trifluorometil-fenil)-metil-n-(6-morfolin-4-il-4-0-tolil-piridin-3-il)-isobutiramida | |
DE50000124D1 (de) | Stanzniet | |
ATE277912T1 (de) | Pyrimidine-2,4,6-trione als matrixmetalloproteinase-hemmer | |
DE50012719D1 (de) | Holster | |
DE50007899D1 (de) | Beta-alaninderivate | |
DE60025958D1 (de) | 14,15-beta-methylen substituierte androgene | |
NO20032291D0 (no) | Pyrimidinderivater | |
DE60027180D1 (de) | Korrelator | |
DK1294729T3 (da) | 2-aminoalkyl-thieno[2,3-d]pyrimidiner | |
ATE286030T1 (de) | 1,4,5,6 -tetrahydropyrimidine-derivative als vitronectin-hemmer | |
FI991074A0 (fi) | Harava | |
ITRM990062U1 (it) | Progetto x | |
ES1042877Y (es) | Lama bi-cama. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1153015 Country of ref document: EP |
|
REN | Ceased due to non-payment of the annual fee |